1. The effects of Japanese encephalitis virus antibodies on Zika virus infection.
- Author
-
He, Xiaoen, Lang, Xinyue, Yu, Jianhai, Zhu, Li, Qin, Zhiran, Liu, Xuling, Chen, Pei, Dai, Chengguqiu, Chen, Tingting, Li, Xujuan, Chen, Yangyang, Zhou, Dongrui, Fang, Wanyi, Xiao, Weiwei, Zhang, Bao, Xie, Qian, Wu, Qinghua, and Zhao, Wei
- Subjects
- *
JAPANESE encephalitis viruses , *ZIKA virus infections , *ZIKA virus , *VIRAL antibodies , *AGE groups - Abstract
Recently, Zika virus (ZIKV) has become more widespread, thus attracting global attention. The vaccine against Japanese encephalitis virus (JEV) is currently used in China, being included in planned immunisation regimes. Although ZIKV and JEV are closely related mosquito-borne Flaviviruses, and a complex cross-immune response within flaviviruses has been demonstrated, the effect of JEV vaccination on ZIKV infection has not been well described. Thus, this study aimed to explore the impact of different titres of anti-JEV antibodies (Abs) against ZIKV infection using sera from healthy human donors in Guangzhou and anti-JEV rabbit polyclonal antibodies (pAbs) in vitro and vivo. Human anti-JEV Ab titres were tested at decreasing concentrations as the age increased. A neutralising effect on ZIKV infection was observed when anti-JEV Ab titres in human sera or rabbit pAbs were high (the corresponding age was under 30 years). Even though a lower titre in human sera showed no apparent effect, whereas rabbit pAbs had an antibody-dependent enhancement(ADE)effect, we proved an ADE effect in vivo for the first time. This study suggests that individuals over 60 years of age are at high risk for JEV and ZIKV infection, and screening this age group for infection should strengthen. Furthermore, a deep exploration of the relationship between anti-JEV Abs and ZIKV infection is needed. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF